期刊文献+

肺动脉高压神经调控机制研究进展

Advances in neuromodulation of pulmonary hypertension
原文传递
导出
摘要 肺动脉高压是一种以肺血管阻力增加、肺血管系统的不良性重塑为特征,导致右心肥厚并最终因右心衰而死亡的进行性疾病。其准确发病机制尚未完全明确,在众多机制中,自主神经功能紊乱也是促成肺动脉高压的因素之一。在肺动脉高压中,交感神经过度激活是公认的一种假说,肺动脉去神经术治疗肺动脉高压取得了一定的疗效。本文对肺血管的神经解剖基础、神经调控参与的肺动脉高压发生发展的可能机制及神经调控在肺动脉高压治疗中的应用进行系统性综述。 Pulmonary hypertension is a progressive disease characterized by an increase in pulmonary vascular resistance,leading to unfavorable pulmonary vascular remodeling.This condition eventually leads to right ventricular hypertrophy and ultimately death from right ventricular failure.Although the exact pathogenesis of pulmonary hypertension remains unclear,autonomic nervous system dysfunction is recognized as one of the contributing factors.Increasing evidence supports the hypothesis that activation of the sympathetic nervous system plays a role in the development of pulmonary hypertension.In addition,pulmonary artery denervation has shown some effectiveness in the treatment of this condition.This article provides a comprehensive review of the neuroanatomical basis of the pulmonary vessels,the potential mechanisms underlying the onset and progression of pulmonary hypertension in relation to neuromodulation,and the application of neuromodulation techniques in its treatment.
作者 侯池 温冬梅 王健 Hou Chi;Wen Dongmei;Wang Jian(State Key Laboratory of Respiratory Diseases,National Center for Respiratory Medicine,National Clinical Research Center for Respiratory Diseases,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Gmu-gibh Joint School of Life Sciences,Guangzhou Medical University,Guangzhou 511436,China)
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2023年第9期936-940,共5页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 国家自然科学基金(82120108001,8224100322) 国家重点研发计划(2022YFE0131500)。
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部